@TENET
Do you have a take on this?
Does this data
prove that these new vaccines are more effective for white people than it is for black and asians? And if so is the difference significant?
No it doesn't
prove that. It is saying that this is a possible risk that there is a difference in effectiveness because some combinations were not (sufficiently) tested.
While not being proof, it does potentially
undermine the results of the phase III trials in that the published headline efficacy rates
might not be the same for different racial groups.
Undermining (or even invalidating the result) does not automatically prove the opposite. Normally the proposition in question just reverts back to being an open, unanswered question.
-
It's also worth noting that it's would not be surprising to get different effectiveness rates as you re-partition the test group in different ways; some example of this being age, co-morbidities, vitamin D levels, professions, gender and so on.
The problem here is that the paper suggests that rather than this problem just being a flaw in the testing, they are saying that flaws in the design itself could be at the root of potentially skewed (and hence biased) results.
-
So a lot of weighing up of probabilities and no certainties ... yet. I am not a medical professional of any sort but if I were to look into it further I would start by reading up about the peptides issue.
My personal opinion is that the vaccines haven't been tested enough.
y’all keep playing with ya lives with this Rona if you want 
had a very grim relization that how America is handling COVID is how they'll handle the problems coming with climate change.
